Orally-Available Ophthalmic Treatments
Adverum is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Through directed evolution, we generate a diverse library of millions of AAV ...
Eye scanning diagnostic
Eyenovia is a clinical stage, ophthalmic biopharmaceutical company transforming the delivery of therapeutics for the treatment of prominent eye diseases, such as glaucoma, dry eyes, allergic eye ...
Isarna Therapeutics develops TGF-β inhibitors to effectively treat ophthalmic and fibrotic diseases and fight cancer. The company uses novel oligonucleotides and combination modalities to ...
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and ...
Ocular drug delivery system
NIghtstar is a leading clinical-stage gene therapy company focused on developing and commercializing novel, one-time treatments for patients suffering from rare inherited retinal diseases that ...
Ocular surgical solutions
OMEICOS Therapeutics’ is focused on developing therapeutics that can be broadly deployed in inflammatory, cardiovascular, ophthalmology and other disease indications using its proprietary ...
Small Molecules, vision and ocular related diseases, and Huntington's disease treatments
The company develops therapeutics designed to repair the retina.
Ophthalmology Clinical Research
Noninvasive, Robotic Eye Treatments
Glaucoma-management contact lens
Group of Many Small Drug and Diagnostic Companies